Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
Esther Schoutrop, Lidia Moyano‐Galceran, Stéphanie Lheureux, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 207-223
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Heterogeneity and treatment landscape of ovarian carcinoma
Ana Veneziani, Eduardo González-Ochoa, Husam Alqaisi, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 12, pp. 820-842
Closed Access | Times Cited: 65
Tumor microenvironment in ovarian cancer peritoneal metastasis
Shuangshuang Mei, Xing Chen, Kai Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 46
Exploring Strategies to Prevent and Treat Ovarian Cancer in Terms of Oxidative Stress and Antioxidants
Yanru Long, Houhui Shi, Jiatian Ye, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 114-114
Open Access | Times Cited: 2
Vaginal microbiota transplantation is a truly opulent and promising edge: fully grasp its potential
Yiming Meng, Jing Sun, Guirong Zhang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 15
Biomarkers in Ovarian Cancer: Towards Personalized Medicine
Carlos López-Portugués, Marı́a Montes-Bayón, Paula Díez
Proteomes (2024) Vol. 12, Iss. 1, pp. 8-8
Open Access | Times Cited: 10
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Preclinical study of inetetamab combined with atezolizumab to synergistically inhibit HER2 and PD-L1 in the treatment of ovarian cancer
Feiquan Ying, Xuyang Zhou, Mengqing Chen, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200938-200938
Open Access | Times Cited: 1
Photodynamic Therapy in Cancer: Insights into Cellular and Molecular Pathways
Vincenzo Papa, Fabiana Furci, Paola Lucia Minciullo, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 69-69
Open Access | Times Cited: 1
Integrative prognostic modeling of ovarian cancer: incorporating genetic, clinical, and immunological markers
Aidi Lin, Feifei Xue, Chenxiang Pan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Trogocytosis and cross-dressing in antigen presentation
Patrick Schriek, José A. Villadangos
Current Opinion in Immunology (2023) Vol. 83, pp. 102331-102331
Closed Access | Times Cited: 22
Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis
Emanuela Anastasi, Antonella Farina, Teresa Granato, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10479-10479
Open Access | Times Cited: 18
Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway
Yazhu Zou, Zitong Zhao, Jingjing Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3099-3114
Open Access | Times Cited: 14
Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression
Ya-Nan Pi, Qiushi Feng, Fusheng Sun, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 11, pp. 2382-2392
Open Access | Times Cited: 14
Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer
Leonard Frisbie, Catherine A. Pressimone, Emma Dyer, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114551-114551
Open Access | Times Cited: 5
Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer
Zhihao Zhao, Qilin Wang, Fang Zhao, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Regulation of Age-Related Lipid Metabolism in Ovarian Cancer
Jihua Feng, Clay Douglas Rouse, Lila Taylor, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 320-320
Open Access
Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
Julia S. Hillmann, Nicolaì Maass, Dirk Bauerschlag, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer
Connor Wang, Maria Gomez-Roas, Emily Hinchcliff
Advances in Oncology (2025)
Closed Access
Investigation of the mechanism by which FOXJ2 inhibits proliferation, metastasis and cell cycle progression of ovarian cancer cells through the PI3K/AKT signaling pathway
Liyuan Wang, Han He, Ruifang Zhai, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Eliza Turlej, Aleksandra Domaradzka, Justyna Radzka, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 403-403
Open Access
Inhibition of Ovarian Cancer Growth, Metastasis and Reverse the Tumor Microenvironment by Dual Drug-Loaded Polymer Micelle Targeting Tumor Microenvironment
Lu Zhang, Rui-bo Guo, Muhan Chen, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2969-2990
Open Access
Single nucleotide polymorphisms in ovarian cancer impacting lipid metabolism and prognosis: an integrated TCGA database analysis
Haoyu Wang, Tian Ming Tu, Lijun Yin, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
GSH-responsive nanoparticles enhance ovarian cancer chemo-immunotherapy via DNA damage repair pathway inhibition and cGAS-STING pathway activation
Miao Ao, Hongyi Hou, Libin Chen, et al.
Nano Today (2025) Vol. 62, pp. 102729-102729
Open Access
HKDC1 promotes ovarian cancer progression through boosting lipid metabolism and immune escape by stabilizing G6PC/G6PC2
Ying Wang, Juan Chen, Zhan Wang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
TRIM25 facilitates ferroptosis in ovarian cancer through promoting PIEZO1 K63-linked ubiquitination and degradation
Ya Li, Fei Zhou, Zhengmei Xu
Translational Oncology (2025) Vol. 56, pp. 102386-102386
Closed Access
Page 1 - Next Page

Scroll to top